Evolve Biosystems
Davis
About Evolve Biosystems
Evolve Biosystems is a biotechnology company that specializes in providing microbiome-based products designed to develop, restore, and maintain. The company's platform focuses on solving the gut dysbiosis throughout the human life cycle as well as in various animal species, enabling physicians to maintain the healthy gut microbiome in newborn infants with a consumer-directed home use product, and a hospital-based neonatal ICU product.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $125.0M
- Funding stage: Late Stage Venture
- Last round: Series D (Feb 2021)
- Website: evolvebiosystems.com
- Phone: +1 415 608 5316
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/evolve-biosystems-107217 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.